6533b830fe1ef96bd1297a16

RESEARCH PRODUCT

P-066 S-1 in combination with epirubicin and oxaliplatin (EOS) in Caucasian patients (pts) with advanced or metastatic gastric cancer (AGC): Results of a phase I study

P. ScigallaMarkus MoehlerM. TesarovaWasat MansoorVolker HeinemannF. BivilleR. MahlbergP. JandaE. KubalaArndt WeinmannBohuslav MelicharRadka Obermannova

subject

OncologyBrachial Plexus Neuritismedicine.medical_specialtybusiness.industryHematologyOxaliplatinMetastatic gastric cancerPhase i studyOncologyInternal medicinemedicinebusinessmedicine.drugEpirubicinhttps://doi.org/10.1093/annonc/mdv233.66